454 related articles for article (PubMed ID: 2840160)
1. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
2. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
Boughton-Smith NK; Whittle BJ
Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses.
Higgs GA; Follenfant RL; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):547-51. PubMed ID: 2840161
[TBL] [Abstract][Full Text] [Related]
4. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
5. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL
Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs.
Payne AN; Garland LG; Lees IW; Salmon JA
Br J Pharmacol; 1988 Jun; 94(2):540-6. PubMed ID: 3395791
[TBL] [Abstract][Full Text] [Related]
7. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
9. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J
Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286
[TBL] [Abstract][Full Text] [Related]
10. Release of PAF-acether and eicosanoids from guinea-pig alveolar macrophages by FMLP: effect of cyclo-oxygenase and lipoxygenase inhibition.
Fitzgerald MF; Parente L; Whittle BJ
Eur J Pharmacol; 1989 May; 164(3):539-46. PubMed ID: 2548873
[TBL] [Abstract][Full Text] [Related]
11. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep.
Coggeshall JW; Christman BW; Lefferts PL; Serafin WE; Blair IA; Butterfield MJ; Snapper JR
J Appl Physiol (1985); 1988 Sep; 65(3):1351-9. PubMed ID: 2846494
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
14. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase.
Salmon JA; Tilling LC; Moncada S
Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen peroxide inhibits alveolar macrophage 5-lipoxygenase metabolism in association with depletion of ATP.
Sporn PH; Peters-Golden M
J Biol Chem; 1988 Oct; 263(29):14776-83. PubMed ID: 2844785
[TBL] [Abstract][Full Text] [Related]
17. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
18. Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.
Hawthorne AB; Boughton-Smith NK; Whittle BJ; Hawkey CJ
Gut; 1992 Apr; 33(4):513-7. PubMed ID: 1316305
[TBL] [Abstract][Full Text] [Related]
19. Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood.
Sweeney FJ; Eskra JD; Carty TJ
Prostaglandins Leukot Med; 1987 Jun; 28(1):73-93. PubMed ID: 3039537
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of 5-lipoxygenase and cyclo-oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes.
Moroney MA; Forder RA; Carey F; Hoult JR
Br J Pharmacol; 1990 Sep; 101(1):128-32. PubMed ID: 2178012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
